Wire Stories
Dr. Reddy’s Laboratories enters into a licensing agreement with Slayback Pharma to obtain exclusive rights in the first-to-file ANDA for the private label version of Lumify� in the U.S.
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–$RDY #Alcon–Dr. Reddy�s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries...